Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Access here alternative investment news about Temasek-backed Chinese Firm Innovent Biologics Plans $422M Hk Ipo
LPNEWS

Temasek-backed Chinese Firm Innovent Biologics Plans $422M Hk Ipo

by dealstreetasia.com posted 8months ago 46 views
Chinese biotech firm Innovent Biologics is looking to raise up to $422 million in its Hong Kong IPO, three sources said, in what could be the biggest biotech IPO in the financial hub this year. Innovent, which is backed by mutual fund giant Fidelity and Singapore state investor Temasek, has... Read more » The post Temasek-backed Chinese firm Innovent Biologics plans $422m HK IPO appeared first on DealStreetAsia.

In this article